- Home
- ALLO vs APPS Comparison
ALLO vs APPS Comparison
Compare ALLO & APPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLO
- APPS
- Stock Information
- Founded
- ALLO 2017
- APPS 2007
- Country
- ALLO United States
- APPS United States
- Employees
- ALLO N/A
- APPS N/A
- Industry
- ALLO Biotechnology: Biological Products (No Diagnostic Substances)
- APPS Multi-Sector Companies
- Sector
- ALLO Health Care
- APPS Miscellaneous
- Exchange
- ALLO Nasdaq
- APPS Nasdaq
- Market Cap
- ALLO 277.8M
- APPS 243.8M
- IPO Year
- ALLO 2018
- APPS N/A
- Fundamental
- Price
- ALLO $1.40
- APPS $4.98
- Analyst Decision
- ALLO Strong Buy
- APPS Hold
- Analyst Count
- ALLO 9
- APPS 3
- Target Price
- ALLO $8.44
- APPS $2.33
- AVG Volume (30 Days)
- ALLO 2.6M
- APPS 4.0M
- Earning Date
- ALLO 08-06-2025
- APPS 08-06-2025
- Dividend Yield
- ALLO N/A
- APPS N/A
- EPS Growth
- ALLO N/A
- APPS N/A
- EPS
- ALLO N/A
- APPS N/A
- Revenue
- ALLO N/A
- APPS $483,577,000.00
- Revenue This Year
- ALLO N/A
- APPS N/A
- Revenue Next Year
- ALLO N/A
- APPS $6.49
- P/E Ratio
- ALLO N/A
- APPS N/A
- Revenue Growth
- ALLO N/A
- APPS N/A
- 52 Week Low
- ALLO $0.86
- APPS $1.18
- 52 Week High
- ALLO $3.78
- APPS $6.86
- Technical
- Relative Strength Index (RSI)
- ALLO 56.45
- APPS 57.47
- Support Level
- ALLO $1.27
- APPS $4.15
- Resistance Level
- ALLO $1.51
- APPS $5.46
- Average True Range (ATR)
- ALLO 0.11
- APPS 0.49
- MACD
- ALLO 0.04
- APPS -0.00
- Stochastic Oscillator
- ALLO 77.55
- APPS 52.53
About ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.
About APPS Digital Turbine Inc.
Digital Turbine Inc is an independent mobile growth platform. It offers end-to-end products and solutions to all participants in the mobile application ecosystem, enabling brand discovery and advertising, user acquisition and engagement, and operational efficiency for advertisers. Its operating segments are On Device Solutions and App Growth Platform.